EP2422789
Inndælanleg samsetning sem inniheldur natríumdeoxýkólat
Status:
EP Einkaleyfi útrunniðEP appl. date:
8.2.2005EP published:
22.11.2017EP application number:
11166225.0
EP translation filed:
26.2.2018Grant published:
15.3.2018EPO information:
European Patent Register
Max expiry date:
7.2.2025Expiry date:
7.2.2025
Title:
Injectable coposition comprising sodium deoxycholate
Timeline
Today
8.2.2005EP application
22.11.2017EP Publication
26.2.2018Translation submitted
15.3.2018Registration published
7.2.2025Expires
Owner
Name:
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical CenterAddress:
1124 West Carson Street, 90502, Torrance, CA, US
Name:
The Regents of the University of CaliforniaAddress:
1111 Franklin Street, 12th Floor, 94607, Oakland, CA, US
Inventor
Name:
Kolodney, Michael S.Address:
Las Vegas, NV, US
Name:
Rotunda, Adam M.Address:
Irvine, CA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
572879 PDate:
19.5.2004Country:
US
Classification
Categories:
A61K 31/575, A61K 31/765, A61K 31/205, A61P 3/00, A61Q 19/06
Annual fees
Number
Paid
Expires
Payer
Number: 14
Paid: 2.3.2018
Expires: 7.2.2019
Payer: Árnason Faktor
Number: 15
Paid: 18.1.2019
Expires: 7.2.2020
Payer: Sigurjónsson & Thor ehf.
Number: 16
Paid: 20.1.2020
Expires: 7.2.2021
Payer: Sigurjónsson & Thor ehf.
Number: 17
Paid: 19.1.2021
Expires: 7.2.2022
Payer: Sigurjónsson & Thor ehf.
Number: 18
Paid: 19.1.2022
Expires: 7.2.2023
Payer: Árnason Faktor ehf.
Number: 19
Paid: 12.1.2023
Expires: 7.2.2024
Payer: Árnason Faktor ehf.
Number: 20
Paid: 10.1.2024
Expires: 7.2.2025
Payer: Árnason Faktor ehf.